Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, weight loss injections can increase the risk of gallbladder problems, including gallstones and gallbladder inflammation. This is a known, documented side effect listed in the prescribing information for both tirzepatide (Mounjaro) and semaglutide (Wegovy) — and it is worth understanding before you start treatment. The risk is real but not common, and for most people it does not change the clinical picture enough to rule treatment out. What matters is knowing what to watch for and when to act. These are prescription-only medicines; a prescriber reviews your full health history before any decision is made.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It is a question our prescribers hear regularly. A few weeks into treatment, some people develop an unfamiliar discomfort in the upper right abdomen. Most of the time it turns out to be referred gas pain or the kind of indigestion that GLP-1 medicines can produce early on. But gallbladder pain can feel similar at first, and it is worth knowing the difference.
If you want to understand exactly how these medicines interact with the gallbladder, our page on weight loss injections and gallbladder issues sets out the clinical detail clearly. The NHS patient information page for tirzepatide lists gallbladder disease as an uncommon side effect, and the same applies to injectable semaglutide. The mechanism has two parts. First, GLP-1 receptor agonists slow gastric motility, which also affects the rhythmic emptying of the gallbladder, bile that sits longer can become more concentrated and form crystals. Second, losing a significant amount of weight quickly (by any method, not just injections) is itself a well-established trigger for gallstone formation, because fatty tissue releases cholesterol into the bile as it breaks down.
The combination means the risk is higher than background, particularly in the first months of active weight loss. It is not a reason to avoid treatment, but it is a reason to be alert. Knowing what ordinary GI discomfort feels like on these medicines (bloating, mild reflux, transient nausea that peaks after a dose and settles by the middle of the week) helps you notice when something feels genuinely different.
Most gallbladder problems that arise during treatment are mild and manageable. Some are not. The following symptoms call for prompt medical assessment, not a note in your diary for next week.
Sharp or severe pain in the upper right side of your abdomen, especially if it radiates to your right shoulder blade or through to your back, is the classic presentation of a gallstone blocking the bile duct or of acute cholecystitis. Fever alongside abdominal pain raises the concern further. Yellowing of the skin or the whites of the eyes (jaundice) suggests bile is backing up into the bloodstream, that is a same-day emergency call. Nausea and vomiting that feels sharply different in character from your usual early-treatment symptoms, or that comes on suddenly after weeks of settling down, also warrants a call to your GP or 111.
Do not try to manage any of those symptoms by pausing your dose and waiting. Contact a healthcare professional the same day. If the pain is severe or you feel very unwell, go to A&E. You can report suspected medicine-related gallbladder events to the MHRA via the Yellow Card scheme, your report contributes to ongoing safety monitoring for these medicines.
For a broader picture of side effects associated with these treatments, the weight loss injections and side effects page covers the full profile, including what to expect during the adjustment phase.
Gallbladder risk is not the same for everyone. Factors that raise it include a personal or family history of gallstones, female sex, being over 40, rapid weight loss, and conditions such as Crohn's disease or haemolytic anaemia. Some people already have silent gallstones (small stones that cause no symptoms) and rapid weight loss can tip them into causing trouble.
If you have already had your gallbladder removed, the picture is different again. Treatment after cholecystectomy is a question worth reading before your consultation, as the clinical considerations shift when the gallbladder is no longer there. People with active gallbladder disease are generally not started on treatment until it is resolved.
At nume, a GPhC-registered Independent Prescriber reads every consultation personally. Gallbladder history (previous stones, inflammation, surgery) is part of what they look at. If your history raises questions, they will address them before any prescription is issued, not flag them after the fact. The clinical team follows the same prescribing standards as any regulated UK prescriber, applying the Mounjaro and Wegovy SmPCs alongside their own clinical judgement.
There is also a related but distinct question: do weight loss injections affect the kidneys? The kidney risk page addresses that separately, because the mechanism and monitoring approach are quite different.
Understanding a side effect is not the same as being afraid of it. Most people taking Mounjaro or Wegovy do not develop significant gallbladder problems. Those who do often catch it early precisely because they knew what to look for.
Practical habits help. Staying well hydrated reduces bile concentration. Eating regular, moderate meals (rather than very long fasting windows) keeps the gallbladder contracting and emptying as it should. Protein adequacy during active weight loss supports a more gradual calorie deficit rather than a sharp drop. None of these replace medical advice, but they are habits any prescriber would endorse alongside treatment.
Keep your medicine in the fridge as directed, but if you are travelling or away from home, carry your pen in a cool bag rather than a handbag left in direct sun, temperature fluctuations affect efficacy, and the Patient Information Leaflet gives the precise room-temperature window for short-term storage.
If you want to understand the full picture of how these medicines relate to the gallbladder, including the latest clinical detail, the weight loss injections and the gallbladder page goes deeper. For a broader overview of what GLP-1 and dual-agonist treatments involve, the guide to weight loss injections is a good starting point. Our prescribers discuss gallbladder history, alongside every other relevant factor, as a standard part of the free consultation, check your eligibility and see whether treatment is clinically suitable for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.